Business
Australia considers six-week gap between Pfizer doses – The Australian Financial Review
A proposal to lengthen the gap between Pfizer’s jabs from three to six weeks is now under consideration by vaccine experts in…
Its a risk-supply equation. Where there is very high risk, as in Sydneys outbreak, and plenty of vaccine, as with AstraZeneca, people can be rushed to the second dose.
Where there is different but significant risk and a shortage of vaccines, as with Pfizer,…
Continue Reading
-
Business14 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General22 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
Business16 hours agoOwn Xero shares? Here are 3 key takeaways from its AGM
-
Business13 hours agoHere’s what analysts expect for the BHP share price in the coming year